Gardening for Health for Cancer Survivors (G4H-CS)

April 29, 2026 updated by: Randall F Holcombe, University of Vermont Medical Center

Gardening for Health for Cancer Survivors (G4H-CS)

This study is testing whether a gardening and nutrition program can improve well-being in people who have had cancer. Many cancer survivors continue to experience challenges after treatment, including changes in appetite, nutrition, stress, and quality of life. Programs that combine healthy eating, physical activity, and social connection may help address these issues.

In this study, participants will take part in a 6-week, in-person program called Gardening for Health. The program includes weekly group sessions held at a garden at the University of Vermont Medical Center. Each session lasts about two hours and includes hands-on gardening activities, nutrition education, cooking demonstrations, and guided wellness practices such as mindfulness and light movement. Participants will also receive educational materials to support healthy eating and gardening at home.

The main goal of the study is to determine whether this program is feasible and acceptable for cancer survivors, meaning whether people are willing to participate, attend sessions, and find the program helpful and satisfying. The study will also explore whether participation is associated with improvements in quality of life, stress, sense of belonging, and nutrition-related behaviours.

Participants will complete questionnaires before starting the program and again after the 6-week program ends. These surveys will ask about overall health, stress levels, social connection, and lifestyle habits.

The researchers hypothesize that participation in the Gardening for Health program will be feasible and well-received by cancer survivors, and that it may lead to improvements in quality of life, reduced stress, and increased feelings of connection and well-being.

This is a single-group study, all participants receive the intervention and there is no comparison group. The results will help determine whether this type of program should be studied further in larger trials.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This is a prospective, single-center, single-arm feasibility study designed to evaluate a structured gardening and nutrition-based intervention, among adult cancer survivors. The study will enroll approximately 15 participants at the University of Vermont Cancer Center.

Cancer survivors frequently experience persistent challenges following treatment, including nutritional deficits, altered taste and appetite, reduced physical activity, psychosocial stress, and decreased quality of life. Prior research has demonstrated that multi-component lifestyle interventions, may improve dietary intake, physical functioning, and psychosocial outcomes. Building on this evidence and prior pilot work conducted at the University of Vermont Medical Center, this study evaluates an adapted, short-duration gardening and nutrition intervention tailored specifically for cancer survivors.

The intervention consists of six weekly, in-person sessions delivered over approximately six weeks in a rooftop garden setting. Each session is approximately two hours in duration and is led by a multidisciplinary team. The intervention integrates hands-on gardening activities, nutrition education, culinary instruction, and experiential components such as mindfulness, light physical activity, and nature-based engagement.

The primary objective is to evaluate feasibility and acceptability of the intervention, assessed through recruitment, retention, attendance, and participant satisfaction. Secondary objectives include assessing pre- to post-intervention changes in psychosocial outcomes, including health-related quality of life, perceived stress, and sense of belonging, as well as exploratory changes in nutrition-related knowledge and behaviors.

Participants will complete self-report assessments at baseline (prior to intervention initiation) and immediately following completion of the intervention. Qualitative feedback collected through post-intervention surveys will be analyzed to characterize participant experience and perceived impact.

This study is not powered to detect statistically significant differences in outcomes but is intended to generate preliminary data on feasibility, acceptability, and potential signals of efficacy to inform the design of future controlled trials.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
15

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 years or older
  • Self-reported current or prior diagnosis of cancer
  • Self-identifies as a cancer survivor
  • Ability to read, write, and speak English

Exclusion Criteria:

  • Currently significantly immunosuppressed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Gardening and Nutrition Intervention for Cancer Survivors
Participants will receive a six-week, in-person gardening and nutrition-based intervention delivered at the University of Vermont Medical Center rooftop garden. The program consists of six weekly sessions, each approximately two hours in duration, led by a multidisciplinary team. Participants will also receive educational materials to support gardening and healthy eating. Outcomes will be assessed using self-report questionnaires administered at baseline prior to the intervention and immediately following completion of the program.
Behavioral: Gardening and Nutrition Intervention

The intervention is a structured, six-week, in-person gardening and nutrition-based program delivered at the University of Vermont Medical Center rooftop garden. Participants will attend one session per week, each approximately two hours in duration, for a total of six sessions. The program is led by a multidisciplinary team.

Each session integrates hands-on gardening activities (e.g., planting, garden maintenance, harvesting), nutrition education (e.g., dietary fiber, hydration, anti-inflammatory foods), and culinary instruction focused on preparing healthy meals. The program also incorporates experiential components such as mindfulness practices, light physical activity, and engagement with natural outdoor environments.

Participants will receive educational materials, including a gardening and nutrition curriculum packet, to support continued application of skills outside of the sessions.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Acceptability of the Gardening and Nutrition Intervention
Time Frame: At 6 weeks (post-intervention)

Acceptability will be assessed using a post-intervention participant satisfaction survey. Measures will include participant-reported satisfaction with the program, perceived usefulness of the intervention components, and willingness to recommend the program to others. Responses will be summarized descriptively to evaluate overall participant satisfaction and perceived value of the intervention.

Responses will be scored on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree).
At 6 weeks (post-intervention)
Recruitment Rate
Time Frame: At 6 weeks (post-intervention)

Recruitment rate will be defined as the number of participants enrolled divided by the number of eligible participants who expressed interest in the study during the recruitment period.

Unit of Measure: Percentage (%) Time Frame: During study enrollment period (up to 6 weeks)
At 6 weeks (post-intervention)
Retention Rate
Time Frame: At 6 weeks (post-intervention)

Retention rate will be defined as the proportion of enrolled participants who complete the full intervention and post-intervention assessments (T2).

Unit of Measure: Percentage (%)
At 6 weeks (post-intervention)
Session Attendance
Time Frame: During the 6-week intervention period

Session attendance will be defined as the number of intervention sessions attended by each participant out of 6 total sessions. Attendance will be summarized as both the mean number of sessions attended and the proportion of sessions attended.

Unit of Measure: Number of sessions (0-6) and Percentage (%)
During the 6-week intervention period
Assessment Completion Rate
Time Frame: At 6 weeks (post-intervention)

Assessment completion will be defined as the proportion of participants who complete all required baseline (T1) and post-intervention (T2) questionnaires.

Unit of Measure: Percentage (%)
At 6 weeks (post-intervention)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in Health-Related Quality of Life (SF-36)
Time Frame: Baseline to 6 weeks

Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The SF-36 evaluates eight domains, including physical functioning, role limitations, emotional well-being, social functioning, pain, energy, and general health. Scores will be calculated according to standard scoring procedures, and changes from baseline to post-intervention will be analyzed.

Each domain score is transformed to a 0 to 100 scale, with higher scores indicating better health-related quality of life.

The outcome will be defined as the change in SF-36 domain scores from baseline (T1) to post-intervention (T2).
Baseline to 6 weeks
Change in Perceived Stress (Perceived Stress Scale)
Time Frame: Baseline to 6 weeks

Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS). The PSS measures the degree to which situations in one's life are perceived as stressful over the past month. The PSS includes 10 items rated on a Likert scale from 0 (never) to 4 (very often), with total scores ranging from 0 to 40. Total scores will be calculated, and changes from baseline to post-intervention will be evaluated. Higher scores indicate greater perceived stress (worse outcome).

The outcome will be defined as the change in total PSS score from baseline (T1) to post-intervention (T2).
Baseline to 6 weeks
Change in Sense of Belonging (General Belongingness Scale)
Time Frame: Baseline to 6 weeks

Sense of belonging will be assessed using the General Belongingness Scale (GBS), which measures feelings of social inclusion and rejection. The GBS consists of 12 items rated on a Likert scale from 1 (strongly disagree) to 7 (strongly agree), with total scores ranging from 12 to 84. Total and subscale scores will be calculated, and changes from baseline to post-intervention will be analyzed.

Higher scores indicate greater sense of belonging (better outcome).
Baseline to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Vermont Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 1, 2028

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 1, 2042

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 1, 2042

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 22, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 29, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 4, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 4, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 29, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • STUDY00004151/UVMCC2602

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Gardening and Nutrition Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings